WHO alerts against India-made cough syrups after 66 children die in Gambia
02:03PM Fri 7 Oct, 2022
The World Health Organisation on Wednesday issued a medical product alert over four cough and cold syrups made by Maiden Pharmaceuticals in India, warning they could be linked to acute kidney injuries and deaths of 66 children in west African nation, The Gambia.
According to reports, the global health body said it is conducting further investigation with the company and regulatory authorities in India.
"Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants," the WHO said.
Addressing a press conference, WHO director general Tedros Adhanom Ghebreyesus said that while the contaminated products have so far only been detected in the Gambia, they may have been distributed to other countries," said at a press conference on Wednesday.
A Reuters report said the New Delhi-based company declined to comment on the matter.
Last month, Gambia's government had said it was also been investigating the deaths, after there was a spike in cases of acute kidney injury among children under the age of five in late July.
(Source: Hindustan Times)